Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Pressure Rises for Regulation of DTC Genetic Tests;Appeal of Stem Cell Ruling Succeeds;Enzyme Approved for Gout;Forest Pharmaceuticals Agrees to Guilty Plea;Company Sold Unapproved and Misbranded Drugs and Obstructed Agency Investigation;DHHS Disbanding Genetics Committee;FDA and Medicare to Join in Product Reviews;NIH,FDA Will Dispense Grants to Advance Regulatory Science;Some Progress on Biosimilars Erythropoietin Recalled Because of Concern About Tiny Glass Flakes from Vials;No Reports of Patient Injuries;Another Role for Pharmacogenomics?;EU to Release Regulations for Biosimilar Antibody Drugs;Another Blow for Patient Protection and Affordable Care Act;Judge Says 20 States Can Proceed with Suit Charging Law Is Unconstitutional